[1]Patent:US2003/235782,2003,A1.Locationinpatent:Page17
[1]CurrentPatentAssignee:MERCKKGAA-US2003/235782,2003,A1Locationinpatent:Page18
[1]CurrentPatentAssignee:CHISSOCORPORATION-JP2019/214542,2019,ALocationinpatent:Paragraph0045;0052-0054
173481-20-4
39181-89-0
177609-12-0 | Fmoc-D-Asp(OAll)-OH | AA0025BQ | MFCD01074688
177970-27-3 | 2H-3,1-Benzoxazine-2,4(1H)-dione, 8-bromo-6-methyl- | AA0025LE | MFCD07439677
178312-48-6 | (4,4-Difluorocyclohexyl)methanol | AA0025UE | MFCD11847775
1204-99-5 | 2,5-Piperazinedione, 3,6-bis[(aminooxy)methyl]- | AA00265X | MFCD01941337
179011-39-3 | 1,5-Difluoro-2-methoxy-4-nitrobenzene | AA0026LQ | MFCD08689675
179324-69-7 | Boronic acid, B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]- | AA0026UO | MFCD09056737
17965-80-9 | [1,5]-Naphthyridin-2-ylamine | AA00273W | MFCD01105747
183251-95-8 | N1,N1-Dimethyl-4-(trifluoromethyl)-1,2-benzenediamine | AA0027DA | MFCD06359952
18366-59-1 | 1-(Thieno[3,2-b]pyridin-6-yl)ethanone | AA0027PM | MFCD19982429
202259-06-1 | 8-(Benzyloxy)-5-bromoquinoline | AA00282I | MFCD03827565